Abstract
Background: Referral of syringe exchange registrants with opioid use disorder to agonist treatment provides a pathway to further reduce drug use risk behaviors. Objective: This study evaluates the drug use risk reduction benefits of enrolling syringe exchange registrants in methadone maintenance, and the impact of continued illicit drug use on risk reduction. Method: Baltimore Needle Exchange Program (BNEP) registrants (n = 210) participated in a parent study evaluating treatment initiation strategies for methadone maintenance and were followed for six months. The Risk Assessment Battery (RAB; Metzger, 1993) was administered monthly to evaluate drug use risks; urinalysis testing was conducted weekly. Results: Treatment enrollment reduced drug use risk behaviors, and longer treatment episodes resulted in additional, though modest, risk reduction. Use of opioids or cocaine in treatment diminished risk-reduction benefits, though drug use risks declined over time and remained well below baseline levels. Conclusions: These findings demonstrate that methadone maintenance enhances the well-known risk-reduction benefits of syringe exchange participation. Improving coordination between syringe exchanges and treatment facilities may enhance the public health.
Original language | English (US) |
---|---|
Pages (from-to) | 546-551 |
Number of pages | 6 |
Journal | Substance Use and Misuse |
Volume | 56 |
Issue number | 4 |
DOIs | |
State | Published - 2021 |
Keywords
- Syringe exchange
- opioid agonist treatment
- opioid use disorder
ASJC Scopus subject areas
- Health(social science)
- Medicine (miscellaneous)
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health